Xylem Inc. (XYL) Stock Rating Reaffirmed by Cowen and Company
Xylem Inc. (NYSE:XYL)‘s stock had its “outperform” rating restated by analysts at Cowen and Company in a note issued to investors on Wednesday. They currently have a $70.00 target price on the industrial products company’s stock, up from their prior target price of $60.00. Cowen and Company’s price objective points to a potential upside of 16.98% from the stock’s previous close.
Several other research analysts also recently commented on XYL. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and set a $66.00 target price (up from $60.00) on shares of Xylem in a report on Tuesday, August 1st. BMO Capital Markets lifted their target price on Xylem from $60.00 to $65.00 and gave the stock an “outperform” rating in a report on Wednesday, August 2nd. Royal Bank Of Canada lifted their target price on Xylem from $58.00 to $64.00 and gave the stock an “outperform” rating in a report on Wednesday, August 2nd. BidaskClub downgraded Xylem from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Finally, Canaccord Genuity reaffirmed a “hold” rating and set a $50.00 target price on shares of Xylem in a report on Friday, July 28th. Five research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $59.00.
Xylem (NYSE XYL) traded down 0.226% during midday trading on Wednesday, reaching $59.705. The company’s stock had a trading volume of 681,521 shares. Xylem has a 1-year low of $45.60 and a 1-year high of $60.71. The firm has a 50 day moving average price of $56.00 and a 200 day moving average price of $51.57. The firm has a market capitalization of $10.72 billion, a PE ratio of 38.544 and a beta of 1.18.
Xylem (NYSE:XYL) last announced its earnings results on Tuesday, August 1st. The industrial products company reported $0.59 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.57 by $0.02. The firm had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.17 billion. Xylem had a return on equity of 16.02% and a net margin of 7.08%. The business’s quarterly revenue was up 24.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.48 EPS. On average, analysts predict that Xylem will post $2.36 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This news story was first published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/08/09/xylem-inc-xyl-stock-rating-reaffirmed-by-cowen-and-company.html.
In other news, Director Steven R. Loranger sold 66,132 shares of the business’s stock in a transaction dated Thursday, June 29th. The stock was sold at an average price of $55.01, for a total value of $3,637,921.32. Following the transaction, the director now directly owns 65,030 shares of the company’s stock, valued at approximately $3,577,300.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.75% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Asset Planning Services Ltd. boosted its position in shares of Xylem by 0.3% in the first quarter. Asset Planning Services Ltd. now owns 2,107 shares of the industrial products company’s stock worth $106,000 after buying an additional 7 shares in the last quarter. Cribstone Capital Management LLC boosted its position in shares of Xylem by 1,214.6% in the first quarter. Cribstone Capital Management LLC now owns 2,432 shares of the industrial products company’s stock worth $124,000 after buying an additional 2,247 shares in the last quarter. CENTRAL TRUST Co boosted its position in shares of Xylem by 160.3% in the second quarter. CENTRAL TRUST Co now owns 2,655 shares of the industrial products company’s stock worth $146,000 after buying an additional 1,635 shares in the last quarter. FNY Partners Fund LP bought a new position in shares of Xylem during the first quarter worth $151,000. Finally, Federated Investors Inc. PA boosted its position in shares of Xylem by 5.8% in the second quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock worth $182,000 after buying an additional 181 shares in the last quarter. 86.41% of the stock is currently owned by institutional investors.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.